Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • N4-Acetylcytidine: Deciphering Its Role in RNA Structure and

    2026-05-17

    N4-Acetylcytidine: Deciphering Its Role in RNA Structure and Function

    Introduction: The Expanding Frontier of RNA Modification

    RNA modifications have emerged as critical determinants in gene expression, cellular differentiation, and disease progression. Among more than 160 known post-transcriptional marks, N4-Acetylcytidine (ac4C) stands out for its evolutionary conservation and diverse regulatory functions in tRNA, rRNA, and mRNA across all domains of life (source: paper). This article delves into the unique properties of N4-Acetylcytidine (C6648, APExBIO), illuminating how its structure, biochemical behavior, and recent mechanistic insights can empower advanced research in RNA epigenetics and nucleotide metabolism.

    The Biochemical Identity of N4-Acetylcytidine

    N4-Acetylcytidine is a chemically modified nucleoside, characterized by an acetyl group at the N4 position of cytidine. This subtle yet profound alteration influences hydrogen bonding and steric properties, thereby impacting RNA folding, base pairing, and recognition by RNA-binding proteins and enzymes. The APExBIO C6648 product is supplied at high purity (~98%, HPLC and NMR verified), ensuring reproducibility in sensitive applications (source: product_spec).

    • Molecular formula: C11H15N3O6
    • Molecular weight: 285.25 g/mol
    • Solubility: ≥52.6 mg/mL in DMSO, ≥5.24 mg/mL in water (ultrasonic), insoluble in ethanol (source: product_spec)
    • Recommended storage: -20°C, with solutions for short-term use only

    These attributes make N4-Acetylcytidine an ideal standard and substrate for RNA modification studies, nucleotide processing enzyme assays, and structure-function analysis workflows.

    The Biological Significance of N4-Acetylcytidine

    Initially identified in yeast tRNASer, N4-Acetylcytidine is now recognized as a conserved feature in tRNA and rRNA, with emerging roles in mRNA as well. Its installation is context-dependent, frequently targeting central cytidines within CCG motifs. In prokaryotes, ac4C at the wobble position of elongator tRNAMet prevents translational errors, while in eukaryotes, it stabilizes rRNA and tRNA structures by reinforcing base pairing with guanosine (source: paper).

    Recent advances have revealed that ac4C modifications in mRNA can enhance translation elongation when present in coding sequences, or impede initiation when located in the 5' UTR. This duality highlights ac4C's nuanced role in gene regulation, with implications for tumorigenesis, stem cell pluripotency, and immune responses (source: paper).

    Mechanistic Insights: From Substrate Processing to Structural Modulation

    While previous articles such as "Structural Mechanisms of ASCH Domain Proteins in N4-Acetylcytidine Processing" have focused on the molecular architecture of ASCH domain enzymes, this article provides a distinct lens: the functional consequences of ac4C incorporation on RNA structure, stability, and its susceptibility to enzymatic processing.

    The catalytic mechanism of the E. coli amidohydrolase EcYqfB, as elucidated by Meng et al. (source: paper), reveals that EcYqfB converts free ac4C nucleoside into cytidine, but does not remove ac4C from RNA directly. This specificity underscores a metabolic route for ac4C recycling and disposal, distinct from the reversal of RNA modifications. The study further determined that the human TRIP4-ASCH domain can bind both RNA and DNA, with unique substrate preferences compared to its bacterial homologs.

    Reference Insight Extraction: What the Latest Structural Study Means for Assay Design

    The most impactful innovation from the Meng et al. study is the clarification that EcYqfB’s activity is restricted to free ac4C nucleoside rather than ac4C within RNA. This distinction is critical for nucleotide processing enzyme assays, as it guides researchers to use free N4-Acetylcytidine as a substrate when characterizing amidohydrolase activity, rather than RNA-bound forms. The determination of crystal structures for EcYqfB, EOLA1, and TRIP4-ASCH domains further enables rational assay design by highlighting key residues for substrate binding, informing mutagenesis or inhibitor studies (source: paper).

    This mechanistic clarity ensures that experimental workflows targeting ac4C metabolism are both specific and interpretable, reducing confounding results from non-specific or indirect substrate usage.

    Protocol Parameters

    • assay | 52.6 mg/mL (DMSO) | high-throughput screening, enzyme kinetics | Ensures maximal substrate availability for quantitative assays | product_spec
    • assay | ≥5.24 mg/mL (water, ultrasonic) | RNA structure-function analysis | Facilitates preparation of aqueous buffers for in vitro studies | product_spec
    • storage | -20°C | all applications | Preserves chemical integrity and prevents degradation | product_spec
    • application | use free N4-Acetylcytidine as substrate for EcYqfB assays | nucleotide processing enzyme assays | EcYqfB only acts on free ac4C, not RNA-incorporated forms | paper
    • application | short-term use of solutions recommended | sensitive RNA modification studies | Minimizes degradation risk in experimental workflows | workflow_recommendation

    Advanced Applications: Beyond the Conventional

    Where previous resources such as "N4-Acetylcytidine: Molecular Insights and Precision in RNA Modification Studies" emphasize assay optimization, this article bridges molecular insights with advanced applications in RNA epigenetics research and structure-function analysis. By leveraging high-purity N4-Acetylcytidine, researchers can:

    • Probe the effects of ac4C incorporation on RNA folding thermodynamics and ribonucleoprotein complex formation.
    • Dissect the selectivity of nucleotide processing enzymes using defined substrates, as informed by the substrate specificity findings of Meng et al. (source: paper).
    • Develop high-fidelity models of epitranscriptomic regulation by comparing modified versus unmodified RNA in translation assays.
    • Quantitatively analyze ac4C turnover and fate in cell extracts, supported by the knowledge that EcYqfB targets free but not RNA-incorporated ac4C.

    This approach is distinct from "N4-Acetylcytidine: Precision Tools for RNA Modification Analysis", which centers on product reliability and workflow troubleshooting. Here, the focus is on mechanistic understanding and hypothesis-driven experimental design.

    Comparative Analysis: Acetylated Cytidine in Context

    While other modified nucleosides such as pseudouridine or 2'-O-methylated cytidine modulate RNA through different mechanisms, ac4C's unique acetylation pattern directly affects base pairing and local structure. Comparative studies using N4-Acetylcytidine standards can dissect the structural basis of modification-driven function, distinguishing ac4C’s stabilizing effects from the flexibility conferred by other marks.

    In contrast to the workflows reviewed in "N4-Acetylcytidine in RNA Epigenetics: Workflows & Troubleshooting", this article interrogates the physicochemical rationale behind protocol choices—such as solubility limits and substrate selection—arming researchers with the knowledge to tailor their experimental systems for maximum specificity and insight.

    Why This Cross-Domain Matters, Maturity, and Limitations

    The implications of these findings extend beyond basic research. As the regulatory roles of RNA modifications in cancer, stem cell biology, and immunity become clearer, reliable standards like N4-Acetylcytidine empower translational studies aiming to modulate the epitranscriptome therapeutically. However, as noted in the cited structural analysis, the field’s maturity is tempered by incomplete knowledge of ac4C erasers and context-specific effects—highlighting the need for continued mechanistic research (source: paper).

    Conclusion and Future Outlook

    By uniting high-purity chemical standards (C6648, APExBIO) with cutting-edge mechanistic insights, researchers are now equipped to interrogate the role of acetylated cytidine in RNA processing, structural fidelity, and enzymatic turnover with unprecedented precision. The clarified substrate specificity of nucleotide processing enzymes, as revealed by Meng et al., enables targeted assay design and deeper exploration of ac4C's biological impact.

    Looking forward, as new tools emerge for mapping and manipulating RNA acetylation, the combination of rigorous biochemical standards with structural knowledge will be essential for unlocking the full potential of the epitranscriptome in health and disease (source: paper).